This article is more than 5 years old. Information may no longer be current.

VIDEO: New treatment strategy in the making for HIV lipodystrophy

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

BOSTON — Steven K. Grinspoon, MD, professor of medicine at Harvard Medical School, discusses the molecular and clinical implications of visceral adipose tissue accumulation in lipodystrophy.

In his presentation, Grinspoon covered HIV lipodystrophy, which occurs in about 25% of HIV-infected patients. Initially, researchers focused on the drugs to treat the condition but have moved on to focusing on the HIV itself.

Grinspoon also touches on new treatment strategies that would focus on the development of a growth-hormone releasing hormone to selectively reduce visceral fat in HIV lipodystrophy.